Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05960929 · ClinicalTrials.gov registry record · Phase 3
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
A Phase 3 study of Intubation Complication and Death; Neonatal, sponsored by ONY.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 220
- Enrollment target
- 10
- Study locations
NCT05960929 is a Phase 3 study of Intubation Complication and Death; Neonatal that is actively recruiting participants, run by ONY. The registered enrollment target is 220 participants, below the 26,531-participant average among 10 other Intubation Complication trials with a reported enrollment target (99% lower). The trial reports 10 study locations across 9 states.
The verdict
NCT05960929, a Phase 3 study of Intubation Complication and Death; Neonatal, is actively recruiting participants, sponsored by ONY.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 220 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this clinical study is to determine the effectiveness and safety of Infasurf® administered through the InfasurfAero™, a novel oral airway delivery device specifically designed to give Infasurf in a less complicated way and without the need for a breathing tube or interrupting nasal respiratory support.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Infasurf Aero™
Study Locations (10)
Arizona
- St. Josephs Hospital and Medical Center - Phoenix
- Phoenix Children's - Phoenix
California
- Sharp Mary Birch Hospital for Women & Newborns - San Diego
Florida
- University of Florida -Jacksonville - Jacksonville
Hawaii
- Kapi'olani Medical Center for Women & Children - Honolulu
New Jersey
- Jersey Shore University Medical Center - Neptune City
New York
- Sisters of Charity Hospital - Buffalo
Tennessee
- Western TN- Jackson-Madison County General Hospital - Jackson
Utah
- Utah Valley Hospital - Provo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2026-04-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05960929
The ClinicalTrials.gov registry entry for NCT05960929 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,531-participant average among 10 other Intubation Complication trials with a reported enrollment target (99% lower). The listed sponsor is ONY, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Intubation Complication appearing as the primary indexed condition, and to 1 intervention - of which Infasurf Aero™ is the first listed.
NCT05960929 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Arizona, California, Florida.
Frequently Asked Questions
What is clinical trial NCT05960929 about?
NCT05960929 is a clinical study titled "InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS". The purpose of this clinical study is to determine the effectiveness and safety of Infasurf® administered through the InfasurfAero™, a novel oral airway delivery device specifically designed to give Infasurf in a less complicated way and without the need for a breathing tube or interrupting nasal re...
What is the current status of trial NCT05960929?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 220 participants. The study started on 2025-01-01. Estimated completion is 2026-04-01.
What conditions does trial NCT05960929 study?
This clinical trial studies the following conditions: Intubation Complication, Death; Neonatal, Respiratory Distress Syndrome (Neonatal).
What interventions are being tested in trial NCT05960929?
The interventions under investigation include: Infasurf Aero™ (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05960929?
This trial is sponsored by ONY, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05960929 being conducted?
This trial has 10 study locations across Arizona, California, Florida, Hawaii, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intubation Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
RECRUITING
-
Sonographic Assessment of Cricoid Pressure
RECRUITING · NA
-
Optimizing Tracheal Intubation Outcomes and Neonatal Safety
RECRUITING · NA
-
The ED-AWARENESS-2 Trial
RECRUITING · NA
-
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
RECRUITING
-
Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.